This project will support planning and discovery for a publicly available robust data asset that will allow a forum for use of Sentinel-like data to develop and pilot new analytic approaches. Specifically, this project will: 1) assess available data asset types and enumerate key governance and technical challenges expected to be encountered in an implementation of a Data Sandbox engagement environment, and 2) identify solutions and gather requirements.
Rishi J. Desai, PhD, Division of Pharmacoepidemiology and Pharmacoeconomics, Mass General Brigham, Boston, MA
Sebastian Schneeweiss, MD, ScD; Shirley V Wang, PhD, ScM; Luke Zabotka; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Patricia Bright, PhD; Catherine Corey, MSPH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Susan Gruber, PhD, MPH, MS, Putnam Data Sciences, LLC, Cambridge, MA
Michael E. Matheny, MD, MS, MPH, Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, TN
Asif Dhar, MD; Dimitrios Koutsonanos, MD, MPH, MBA; Teress Votto, MPH; Deloitte LLP, Rosslyn, VA
Judith C. Maro, PhD, MS; Jeffrey S. Brown, Ph.D; Victor Novak, MS; Jenny Hochstadt, MSc; Daniel P. Scarnecchia, MPIA; Samantha Smith; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA